CG ONCOLOGY INC (CGON) Forecast, Price Target & Analyst Ratings

NASDAQ:CGON • US1569441009

Current stock price

65.55 USD
-1.27 (-1.9%)
At close:
65.55 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CG ONCOLOGY INC (CGON).

Forecast Snapshot

Consensus Price Target

Price Target
$87.96
+ 34.18% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.59
Revenue Estimate
311.61K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.81%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$87.96
Upside
+ 34.18%
From current price of $65.55 to mean target of $87.96, Based on 21 analyst forecasts
Low
$70.70
Median
$86.70
High
$113.40

Price Target Revisions

1 Month
5.48%
3 Months
10.43%

Price Target Summary

21 Wall Street analysts provided a forecast for the next 12 months for CGON. The average price target is 87.96 USD. This implies a price increase of 34.18% is expected in the next year compared to the current price of 65.55.
The average price target has been revised upward by 10.43% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CGON Current Analyst RatingCGON Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10

Analyst Ratings History

CGON Historical Analyst RatingsCGON Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
83.81%
CGON was analyzed by 21 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CGON.
In the previous month the buy percentage consensus was at a similar level.
CGON was analyzed by 21 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-27RBC CapitalMaintains Outperform -> Outperform
2026-04-17JP MorganMaintains Overweight -> Overweight
2026-04-07HC Wainwright & Co.Maintains Buy -> Buy
2026-02-27HC Wainwright & Co.Maintains Buy -> Buy
2026-02-10Truist SecuritiesMaintains Buy -> Buy
2026-01-21RBC CapitalMaintains Outperform -> Outperform
2026-01-16Piper SandlerMaintains Overweight -> Overweight
2026-01-12Truist SecuritiesMaintains Buy -> Buy
2025-12-11WedbushInitiate Outperform
2025-11-24Truist SecuritiesInitiate Buy
2025-11-17RBC CapitalMaintains Outperform -> Outperform
2025-10-08GuggenheimInitiate Buy
2025-09-26JP MorganMaintains Overweight -> Overweight
2025-09-17Morgan StanleyMaintains Overweight -> Overweight
2025-09-15HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-08Jones TradingInitiate Buy
2025-09-08Cantor FitzgeraldReiterate Overweight -> Overweight
2025-09-08HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-05HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-19Piper SandlerInitiate Overweight
2025-07-16RBC CapitalMaintains Outperform -> Outperform
2025-06-17Morgan StanleyMaintains Overweight -> Overweight
2025-05-19Morgan StanleyMaintains Overweight -> Overweight
2025-05-02JP MorganInitiate Overweight
2025-04-29RBC CapitalMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.59
Revenue Estimate
311.61K
Revenue Q2Q
499.25%
EPS Q2Q
-31.05%
Number of Analysts
15

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
12.54%

Next Earnings Summary

CGON is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.59 USD and the consensus revenue estimate is 311.61K USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CGON revenue by date.CGON revenue by date.
204K
6.81%		1.139M
458.33%		4.04M
254.70%		17.695M
338.00%		135.98M
668.47%		500.02M
267.72%		932.77M
86.55%		1.472B
57.81%		2.129B
44.63%		2.453B
15.22%		2.794B
13.90%
EBITDA
YoY % growth
CGON ebitda by date.CGON ebitda by date.
-55.432M
-57.34%		-114.634M
-106.80%		-189.329M
-65.16%		-242.96M
-28.33%		-208.602M
14.14%		-50.109M
75.98%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
CGON ebit by date.CGON ebit by date.
-55.449M
-57.32%		-114.666M
-106.80%		-190.774M
-66.37%		-237.587M
-24.54%		-239.4M
-0.76%		-34.227M
85.70%		366.41M
1,170.53%		782.41M
113.53%		1.246B
59.25%		1.419B
13.88%		1.599B
12.68%
Operating Margin
CGON operating margin by date.CGON operating margin by date.
-27,180.88%-10,067.25%-4,722.13%-1,342.68%-176.06%-6.85%39.28%53.15%58.53%57.85%57.23%
EPS
YoY % growth
CGON eps by date.CGON eps by date.
N/A-1.42
-4.48%		-2.09
-47.18%		-2.57
-22.78%		-2.10
18.30%		0.08
103.82%		2.72
3,291.88%		5.77
112.29%		9.04
56.72%		10.70
18.27%		11.86
10.90%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.59
-31.05%		-0.62
-15.39%		-0.67
-16.91%		-0.71
-34.54%		-0.59
0.55%		-0.63
-1.49%		-0.67
-0.26%		-0.69
3.45%
Revenue
Q2Q % growth		311.61K
499.25%		326.91K1.55M
-6.96%		12.434M
435.49%		25.5M
8,083.31%		26.622M
8,043.53%		28.764M
1,755.74%		30.804M
147.74%
EBITDA
Q2Q % growth		-52.128M
-23.59%		-56.239M
-15.81%		-58.909M
-16.57%		-66.017M
-39.70%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-53.908M
-27.73%		-57.87M
-18.73%		-62.198M
-21.65%		-58.587M
-20.30%		-54.672M
-1.42%		-58.344M
-0.82%		-61.098M
1.77%		-63.852M
-8.99%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CGON Yearly Revenue VS EstimatesCGON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
CGON Yearly EPS VS EstimatesCGON Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
26.79%
EPS Next 5 Year
36.63%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
546.09%
Revenue Next 5 Year
280.15%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
20.51%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CG ONCOLOGY INC / CGON Forecast FAQ

What do analysts expect the price target to be for CG ONCOLOGY INC (CGON)?

21 analysts have analysed CGON and the average price target is 87.96 USD. This implies a price increase of 34.18% is expected in the next year compared to the current price of 65.55.

Can you provide the upcoming earnings date for CG ONCOLOGY INC?

CG ONCOLOGY INC (CGON) will report earnings on 2026-05-07.

What are the consensus estimates for CG ONCOLOGY INC (CGON) next earnings?

The consensus EPS estimate for the next earnings of CG ONCOLOGY INC (CGON) is -0.59 USD and the consensus revenue estimate is 311.61K USD.

What is the expected long term growth rate for CGON stock?

The expected long term growth rate for CG ONCOLOGY INC (CGON) is 546.09%.